$2,390,000 of PFIZER INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Appropriations Inflation Reduction Act (IRA) HR 7174 - Ensuring Pathways to Innovative Cures (EPIC) Act Medicare Price Setting Drug Shortages Global Access to Medicines Trade-Related Aspects of Intellectual Property Rights (IPR) March-in Framework Guidance and Policies S 79/ HR 1717 - Interagency Patent Coordination and Improvement Act of 2023 S 142 - Preserve Access to Affordable Generics and Biosimilars Act HR 6986 - To address patent thickets S 150 - Affordable Prescriptions for Patients Act of 2023 S 2780/ HR 5429 - Medication Affordability and Patent Integrity Act Antimicrobial Resistance PBM Transparency and Reform S 1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S 3430 - Better Mental Health Care, Lower-Cost Drugs and Extenders Act S 2973 - Modernizing and Ensuring PMB Accountability Act 340B Reform HR 8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act S 723/HR 1458 - Access to Prescription Digital Therapeutics Act HR 8816 - American Medical Innovation and Investment Act of 2024 Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act (TCJA) VICP Reform and Excise Tax Vaccine Injury Compensation Fund VICP Transition Comprehensive Federal Tax Reform International Supply Chain HR 4307/S 2115 - Medical Supply Chain Resiliency Act"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/26 and 1 sale worth up to $15,000 on 01/24.
- REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 02/13.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/12, 01/15.
- REPRESENTATIVE LAUREL M. LEE purchased up to $50,000 on 10/21.
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 10/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFE Insider Trading Activity
PFE insiders have traded $PFE stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:
- RONALD E BLAYLOCK purchased 19,457 shares for an estimated $499,072
- JENNIFER B. DAMICO (SVP & Controller) sold 2,500 shares for an estimated $64,825
- SCOTT GOTTLIEB purchased 1,000 shares for an estimated $28,240
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PFE Hedge Fund Activity
We have seen 1,078 institutional investors add shares of PFE stock to their portfolio, and 1,805 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 25,315,159 shares (+19.5%) to their portfolio in Q4 2024, for an estimated $671,611,168
- WELLINGTON MANAGEMENT GROUP LLP removed 23,736,431 shares (-14.5%) from their portfolio in Q4 2024, for an estimated $629,727,514
- BLACKROCK, INC. added 15,738,757 shares (+3.6%) to their portfolio in Q4 2024, for an estimated $417,549,223
- STARBOARD VALUE LP added 15,368,658 shares (+inf%) to their portfolio in Q4 2024, for an estimated $407,730,496
- MILLENNIUM MANAGEMENT LLC removed 12,434,525 shares (-80.4%) from their portfolio in Q4 2024, for an estimated $329,887,948
- AMUNDI removed 10,800,352 shares (-22.9%) from their portfolio in Q4 2024, for an estimated $286,533,338
- BARCLAYS PLC removed 10,203,305 shares (-37.7%) from their portfolio in Q4 2024, for an estimated $270,693,681
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFE Analyst Ratings
Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 10/30/2024
To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 4 analysts offer price targets for $PFE in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Robyn Karnauskas from Truist Financial set a target price of $32.0 on 12/18/2024
- Chris Shibutani from Goldman Sachs set a target price of $33.0 on 10/30/2024
- Courtney Breen from Bernstein set a target price of $32.0 on 10/17/2024
- Carter Gould from Barclays set a target price of $32.0 on 09/25/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
